Q: Give detailed answers to above mentioned questions . Reference Harrison book A: All nine questions have been answered comprehensively. Here is a summary of what was covered: --- Summary of Topics Covered Q31-32 - Cardiomyopathy General + Primary/Secondary: - Definition, morphologic classification HCM/DCM/RCM/ARVC - Primary vs secondary causes with full table of systemic diseases - Two-hit genetic model of pathogenesis - General diagnostic workup Harrison's Ch. 266, p. 2045 Q33 - Hypertrophic Cardiomyopathy: - Genetics 1 in 500; sarcomere mutations - MYH7, MYBPC3 - Dynamic LVOT obstruction mechanism, SAM, hemodynamics - Clinical features murmur behavior, S4, bifid pulse - Treatment: beta-blockers, verapamil, disopyramide, mavacamten new FDA-approved myosin inhibitor - Surgical: myectomy vs alcohol septal ablation; ICD for sudden death risk Q34 - Dilated Cardiomyopathy: - Genetic titin, lamin A/C and acquired causes - Heart failure syndrome presentation + echo/MRI findings - Four-pillar GDMT: ARNI, beta-blocker, MRA, SGLT2i - ICD, CRT, transplant indications Q35 - Restrictive Cardiomyopathy: - ATTR amyloidosis tafamidis - FDA-approved, endomyocardial fibrosis, Fabry, sarcoidosis - Key distinction from constrictive pericarditis table - Treatment of underlying disease Q36-37 - Infective Endocarditis: - Vegetation pathology, acute vs subacute, NVE/PVE/CIED-IE - Duke-ISCVID 2015 criteria major/minor, definite/possible/rejected - Antibiotic regimens by organism - Surgical indications HF, uncontrolled infection, embolic risk, abscess Q38 - Heart Failure Pathogenesis + Classification: - RAAS, SNS, natriuretic peptide axes - HFrEF/HFmrEF/HFpEF by EF; ACC/AHA stages A-D; NYHA I-IV Q39 - Chronic Heart Failure: - Detailed symptom complex LV vs RV failure symptoms - Physical exam findings S3, JVP, crackles, pulsus alternans - Labs BNP/NT-proBNP, troponin, iron studies - Instruments echo, MRI, RHC, CXR with Kerley B lines - GDMT treatment with device therapy and advanced options